Oct 5 – 7, 2026
Hotel Berlin, Berlin
Europe/Berlin timezone
>> Announcement: All results of the review process have been sent via email. <<

Prevalence and associated factors of severe mpox in Mbarara City, southwestern Uganda, October 2024–May 2025

Oct 6, 2026, 3:00 PM
15m
Hall "Berlin"

Hall "Berlin"

Oral presentation Public Health Session 8: Public Health II

Speaker

Justine Wobusobozi (Field epidemiologist)

Description

Background: In October 2024, Mbarara City, Uganda, experienced sustained mpox transmission, with Nyamityobora Ward being disproportionately affected. Data on factors associated with severe disease were limited. We determined the prevalence and factors associated with severe mpox in Nyamityobora Ward during October 2024–May 2025.
Methods: We conducted a cross-sectional study using active case finding among suspected mpox cases in Nyamityobora Ward from April to May 2025. Disease severity was assessed using an adapted Mpox Severity Scoring System (MPSSS) and dichotomized as severe versus non-severe. Modified Poisson regression was used to identify associated factors.
Results: Of 106 mpox cases identified, 62 (59%) had severe disease. The median age was 29 years and 55% were female. HIV co-infection (adjusted prevalence ratio [aPR] 1.8, 95% CI 1.2–2.7), delayed care-seeking >5 days (aPR 1.5, 95% CI 1.1–2.1) and sex work (aPR 1.4, 95% CI 1.0-2.0; p= 0.045) were independently associated with severe mpox.
Conclusion: Severe mpox was common and strongly associated with HIV co-infection, delayed care-seeking and sex work. Integrating mpox screening into HIV services and promoting early care-seeking and implementing targeted interventions for sex workers may reduce severe outcomes during outbreaks.

Keywords

Mpox, Severity, Uganda, HIV co-infections, Cross-sectional study, Prevalence

Registration ID 49
Professional Status of the Speaker Graduate Student
Junior Scientist Status Yes, I am a Junior Scientist.

Author

Justine Wobusobozi (Field epidemiologist)

Co-authors

Dr Martha.D. Nalweyiso (Field epidemiologist) Dr Michael Mutegeki (Field epidemiologist)

Presentation materials

There are no materials yet.